Xencor Names New Board Member

Monrovia-based biopharmaceuticals firm Xencor announced this morning that it has added A. Bruce Montgomery, M.D., to its board of directors. Montgomery is currently the CEO of Cardeas Pharma, and was a SVP at Gilead Sciences; he also was CEO of Corus Pharma, and served at PathoGenesis Corporation. Xencor is developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer.